Inhibition of platelet GPIIbIIIa prolongs survival of discordant cardiac xenografts.
Lesnikoski
B A
BA
Sandoz Center for Immunobiology, New England Deaconness Hospital, Boston, Massachusetts 02215, USA.
Candinas
D
D
Hancock
W W
WW
Otsu
I
I
Siegel
J
J
Bach
F H
FH
Robson
S C
SC
D000818:Animals; D001596:Benzylamines; D004546:Elapid Venoms / Q000627:therapeutic use; D006085:Graft Survival / Q000187:drug effects; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D051381:Rats; D011917:Rats, Inbred Lew; D014183:Transplantation, Heterologous / Q000502:physiology*
D001596:Benzylamines; D004546:Elapid Venoms; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; C099231:SDZ GPI 562; C016310:cobra venom factor